Microglia activation induces oxidative injury and decreases SIRT3 expression in dopaminergic neuronal cells

Area of Science:

• Neuroscience
• Cell Biology
• Pathology

Background:

• Neuroinflammation driven by microglia activation is implicated in Parkinson's disease (PD) pathogenesis.
• The specific impact of microglia activation on dopaminergic neuronal cell (DAC) survival remains unclear.

Purpose of the Study:

• To investigate the neurotoxic effects of microglia activation-induced oxidative injury on DACs.
• To elucidate the underlying molecular mechanisms contributing to DAC apoptosis and cell cycle arrest.

Main Methods:

• Utilized microglia-DAC co-culture systems (BV-2/MN9D cells and primary microglia/mesencephalic neurons).
• Induced microglia activation using lipopolysaccharide (LPS).
• Assessed intracellular reactive oxygen species (ROS) levels, apoptosis rates, cell cycle progression, mitochondrial function, and gene/protein expression (Bcl-2, Bax, caspase-3, SIRT3, SOD2).

Main Results:

• LPS-induced microglia activation increased ROS accumulation and DAC apoptosis, arresting cells in the G1 phase.
• Apoptosis involved mitochondrial permeability transition pore opening, membrane depolarization, and altered Bcl-2/Bax/caspase-3 expression in DACs.
• Microglia activation significantly reduced SIRT3 and superoxide dismutase 2 (SOD2) gene expression in DACs.

Conclusions:

• Microglia activation promotes DAC apoptosis through mitochondrial pathways.
• Reduced SIRT3 expression in DACs is a key mechanism linking neuroinflammation to neurodegeneration in PD.
• These findings offer insights into how neuroinflammation contributes to Parkinson's disease progression.